HB3003 EnrolledLRB098 10952 HLH 41560 b

1    AN ACT concerning State government.
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4    Section 5. The Department of Public Health Powers and
5Duties Law of the Civil Administrative Code of Illinois is
6amended by adding Section 2310-349 as follows:
7    (20 ILCS 2310/2310-349 new)
8    Sec. 2310-349. The Childhood Cancer Research Board.
9    (a) The Childhood Cancer Research Board is created as an
10advisory board within the Department. The Board shall consist
11of 11 members as follows: 2 members appointed by the President
12of the Senate; one member appointed by the Minority Leader of
13the Senate; 2 members appointed by the Speaker of the House of
14Representatives; one member appointed by the Minority Leader of
15the House of Representatives; 2 members appointed by the
16Governor, one of whom shall be designated as chair of the Board
17at the time of appointment; and 2 members appointed by the
18Director. The Director, or his or her designee, shall serve as
19an ex officio member of the Board. Members appointed under this
20Section shall be experts in pediatric cancer or members of the
21General Assembly; however, no appointing authority may appoint
22more than one member of the General Assembly to serve during
23the same term. For the purposes of this Section, an "expert in



HB3003 Enrolled- 2 -LRB098 10952 HLH 41560 b

1pediatric cancer" is defined as a physician or scientist who
2(i) holds a position of leadership in an internationally
3recognized program of pediatric cancer research at the time of
4his or her appointment, or (ii) is a fully tenured professor at
5an institution of higher education. In addition, an expert in
6pediatric cancer must possess at least one of the following
8        (1) a strong track record of publication;
9        (2) participation in a federally-funded pediatric
10    cancer research program;
11        (3) a leadership role in a national cancer research
12    society, including the American Society of Hematology, the
13    American Association of Cancer Research, or the American
14    Society of Clinical Oncology; and
15        (4) participation in a National Cancer Institute or
16    American Cancer Society study section.
17    The Board members shall serve one 2-year term. If a vacancy
18occurs in the Board membership, the vacancy shall be filled in
19the same manner as the initial appointment.
20    (b) Board members shall serve without compensation and
21shall not be reimbursed for necessary expenses incurred in the
22performance of their duties unless funds become available to
23the Board. The Department shall provide staff and
24administrative support services to the Board.
25    (c) The Board must review grant applications, make
26recommendations and comments, and consult with the Department



HB3003 Enrolled- 3 -LRB098 10952 HLH 41560 b

1of Public Health in making grants from amounts appropriated
2from the Childhood Cancer Research Fund to public or private
3not-for-profit entities for the purpose of conducting
4childhood cancer research in accordance with Section 6z-93 of
5the State Finance Act.
6    (d) Grants shall be awarded to research projects that fall
7within the following categories:
8        (1) understanding the basic biology of specific
9    pediatric cancers using cellular and animal models;
10        (2) pre-clinical studies that translate basic
11    observations into novel diagnostics or therapeutic agents
12    specific to pediatric cancer; or
13        (3) support of Phase I clinical trials of new agents
14    developed at Illinois institutions.
15    (e) The Board shall make its recommendations to the
16Department no later than March 1 of the year after the
17application is received.